BRAIDWELL LP 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:06 pm Sale |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BRAIDWELL LP | 2,385,623 2.920% |
-2,213,861 (-48.13%) |
Filing |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
BRAIDWELL LP | 4,599,484 6.680% |
4,599,484 (New Position) |
Filing |